HYPOXIC - ISCHEMIC ENCEPHALOPATHY. GENERAL PRINCIPLES
The brain is about 2% of the total body mass but consumes 15% of the energy generated in the body. Most of this energy is used by neurons to maintain ionic gradients that are important for conductivity and synaptic function. Some energy is also needed to support synthetic and catabolic activity of neurons and glial cells and, in young age, for growth. Energy for these functions is derived from hydrolysis of ATP. Thus, the brain is like a chemical battery of ATP which must be constantly recharged. The brain has no energy stores of its own except for a small amount of glycogen in astrocytes. Anaerobic glycolysis of this glycogen is insufficient to meet energy needs. Fatty acids cannot be used because they are not transported across brain capillaries. Brain cells have no back up energy source such as creatine phosphate that muscle cells have. Consequently, energy for recharging the ATP battery is derived exclusively from oxidative phosphorylation of glucose. Thus, the brain depends on a second by second supply of oxygen and glucose by the blood. A drop in cerebral perfusion, hypoxia, hypoglycemia, and severe anemia can cause a critical shortage of energy (energy crisis). In protracted generalized seizures, neurons use up glucose and oxygen faster than they are supplied, and discharge glutamate (see below) with the same result.The most common cause of energy crisis is a drop of cerebral perfusion (global ischemia), usually resulting from cardiac arrest or severe hypotension (shock). Sustained severe hypoglycemia, and seizures lasting 1-2 hours also cause permanent brain damage. Pure hypoxia in clinical settings is unusual. Patients with lung disease are treated with oxygen and the brain can adapt to pure hypoxia, especially if it develops slowly. Hypoxia develops acutely in CO poisoning, which displaces oxygen from hemoglobin. Global ischemia is worse than hypoxia, hypoglycemia, and seizures because, in addition to causing energy failure, it results in accumulation of lactic acid and other toxic metabolites that are normally removed by the circulation.
The mechanism of neuronal damage in hypoxic-ischemic encephalopathy (HIE) is now beginning to be understood. Obviously, lack of energy causes initially electrical failure and, if it lasts long enough, results in arrest of cellular functions and cell death. However, animal experiments and clinical studies show that there are other factors, in addition to energy loss, that account for neuronal damage. Even sublethal HIE can set in motion a series of toxic reactions that finish off injured neurons and kill additional ones that have not been damaged during the initial insult. Thus, following global ischemia, neurons do not die suddenly or all at once. In some of them, damage develops hours or days after the insult. Most neurons undergo necrosis. In some neurons, HIE triggers apoptosis.
The first result
of energy depletion is failure of Na+ and
K+ pumps, leading
to depolarization of the neuronal membrane
(see diagram on left). Synaptic function and conductivity
cease at this point. Depolarization causes neurons
to release glutamate into the synaptic
cleft. Glutamate is the most common excitatory neurotransmitter.
In small amounts, it is indispensable for neuronal
function. In excessive amounts, it is a neuronal
poison, a toxin, and has been called excitotoxin.
Some glutamate receptors are non-selective cation-permeable
ion channels. Initially, over-activation of these
channels causes a passive influx of Cl- (and
Na+) into
cells causing osmotic (cytotoxic) edema and
rapid death. Additional structural
damage develops hours or days later as a result of Ca++ influx into
neurons.
The NMDA and AMPA receptors of glutamate are channels
that are permeable to Ca++. Activation
of these receptors by excess glutamate causes massive
influx of Ca++ into neurons. Ca++ activates catabolic
enzymes (proteases, phospholipases, endonucleases).
Ca++ also activates NO synthase, resulting
in formation of the free radical NO. Additional
free radicals result from the impairment of oxidative
phosphorylation. Free radicals and activated catabolic
enzymes destroy structural proteins, membrane lipids,
nucleic acids, and other cellular contents, causing
neuronal necrosis. DNA damage from endonucleases
and mitochondrial injury from free radicals trigger
apoptosis. Counteracting the action of glutamate
is the basis of neuroprotective strategies that are
now at an experimental stage.
Incomplete combustion of glucose results in lactic acidosis. Lactic acid can get through cell membranes and can damage not only neurons but glial and mesenchymal cells as well. Additionally, lactic acid and hydrogen ions cause cerebral edema by attracting water. Obviously, lactic acidosis is more severe in patients with HIE who are hyperglycemic and is not a significant factor in hypoglycemic encephalopathy or seizures.
Severe HIE is accompanied by cerebral edema and its effects are compounded by increased intracranial pressure. Cytotoxic (intracellular) edema develops in the initial phase of the insult. Interstitial cerebral edema, which follows, is due to vascular injury and the release in the interstitial space of vasoactive metabolites such as arachidonic and other fatty acids (derived from membrane glycerolipids), lactic acid, electrolytes and other unknown osmoles. Arachidonic acid also has a chemotactic function and induces acute inflammation.
Free radicals, lactic acid, cerebral edema, and inflammation cannot develop in unperfused, completely ischemic tissue. They develop following reperfusion. In an ironic sense, the brain has to be alive in order for the changes of neuronal death to develop. Thus, reperfusion is a double-edged sword. Without it, there is no hope for recovery. On the other hand, reperfusion causes additional (delayed) neuronal injury, brings monocytes to the site of injury, and sustains the glial and vascular reactions that follow. Knowledge of the various aspects of HIE and reperfusion injury may open the way to possible neuroprotective interventions.
THE PATHOLOGY OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY
![]() |
| Anoxic neurons |
With this background, let us examine what happens with different grades of HIE. Suppose that someone has a brief episode of global ischemia, say from fainting. Within seconds, energy failure causes electrical activity in neurons to cease and the patient loses consciousness. Neurons and glial cells are viable and, if circulation is promptly restored, the patient returns to normal. If, however, ischemia lasts longer, first the integrity of cell membranes will be compromised and then cellular metabolism will cease and neurons will die. Ischemia lasting 4-5 minutes can damage irreversibly hippocampal and neocortical pyramidal cells, striatal neurons, and Purkinje cells. More protracted ischemia can damage thalamic and brainstem neurons.
If a patient dies shortly after the insult, the brain is usually grossly and microscopically normal. If the patient survives and perfusion is restored, changes begin to appear within hours. At first, injured neurons shrink and become eosinophilic. This is due to increased density of damaged mitochondria. Neuronal nuclei condense. The shrunken eosinophilic neuron (anoxic neuron) is the hallmark of HIE. Astrocytes swell (Alzheimer type II cells). This is a poorly understood response of astrocytes to metabolic insults. If the patient survives longer, damaged neurons disintegrate and are removed by macrophages. With time, cortical atrophy and gliosis develop.
Some cases of HIE, usually after brief insults, cause neuronal death only without damage of glial cells (selective neuronal necrosis). Neurons are more sensitive than glial cells because they have higher energy demands and only they produce glutamate. Some neurons are more vulnerable than others (selective vulnerability). The hippocampal pyramidal cells of CA1, pyramidal neocortical neurons (layers 3, 5, and 6), Purkinje cells, and striatal neurons have the highest vulnerability.
![]() |
![]() |
| Pseudolaminar necrosis | Pseudolaminar necrosis |
![]() |
![]() |
| Hippocampal sclerosis, left | Hippocampal sclerosis |
The term HIE encompasses hypoxia, ischemia, hypoglycemia, and the efects of prolonged seizures. Shock and cardiac arrest develop at some point in most severe HIE cases, and the neuropathology is the same regardless of the initial event. Only rarely it is possible to identify the cause of HIE based on the pathological findings. For instance, bilateral hippocampal neuronal loss and gliosis (hippocampal sclerosis) without other lesions is seen in some patients with epilepsy or following cardiac arrest of short duration. Sparing of Purkinje cells suggests hypoglycemic encephalopathy but is also seen in HIE without hypoglycemia. In addition to causing hypoxia, CO binds to iron-rich neurons of the globus pallidus and substantia nigra, damaging these nuclei selectively.
![]() |
|
| "Respirator brain" | Non-perfused brain |
In some instances, global ischemia causes bilateral, symmetric cerebral infarcts in the border zones between major arterial territories. Rarely, HIE involves the white matter, causing myelin damage and loss. Unravelling of damaged myelin results in vacuolization and a spongy appearance of the white matter in tissue sections. White matter damage is common in CO poisoning but may occur in other forms of HIE.
THE CLINICAL CONSEQUENCES OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY
The most common pattern of injury in HIE is selective loss of sensitive neurons (pyramidal cells of CA1 of the hippocampus, layers 3, 5, and 6 of the neocortex, Purkinje cells, and striatal neurons). Mild HIE, such as a brief cardiac arrest, may affect CA1 pyramidal neurons of the hippocampus only. Bilateral hippocampal damage (see below) causes Korsakoff's amnesia. This is a memory disorder characterized by inability to retain new information (anterograde amnesia) and a less severe defect of recall of old memories (retrograde amnesia).
Diffuse cortical, thalamic, or combined neuronal loss (with intact brainstem) results in dementia or the persistent vegetative state (loss of cognitive functions and emotion with preservation of sleep-wake cycles, autonomic function, and breathing). The medical, legal, and ethical issues revolving around the persistent vegetative state were dramatized in 2005 by the case of Terri Schiavo.
More protracted ischemic insults, which damage also the brainstem, cause brain death, a terminal clinical state characterized by loss of cerebral and brainstem function. The clinical criteria for brain death are complete unresponsiveness, absence of brain stem reflexes, electrical silence (flat EEG), and absence of cerebral perfusion. The latter is probably due to blockage of capillaries from endothelial swelling and cerebral edema. Brain death can be distinguished clinicallly from the persistent vegetative state and other conditions that cause severe brain damage and coma. In most cases, brain death leads to loss of vital functions. Therefore, for legal purposes, brain death is the equivalent of somatic or cardiorespiratory death.
THE WHITE MATTER IN HIE
Acute HIE damages primarily neurons of the cerebral cortex and deep nuclei. The white matter is only rarely affected. One exception is CO poisoning, in which the white matter is affected, along with but sometimes out of proportion to the pathology in the cortex and basal ganglia. In situations of chronic hypoperfusion, diffuse loss of myelinated axons develops in the subcortical white matter. This can be detected by CT and MRI imaging and has been referred to a "leukoaraiosis" (thinning of the white matter) in the radiological literature. This condition is associated with small vessel disease (hypertension, cerebral amyloid angiopathy, CADASIL-see page 2 and page 3 further on) and causes dementia. The white matter pathology is usually associated with lacunar infarcts and hemorrhages that accompany these conditions.Further reading:
Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391-7. PubMed
MacDonald JF, Xiong ZG, Jackson MF. Paradox of Ca2+ signaling, cell death and stroke. Trends Neurosci. 2006;29:75-81. PubMed
Updated: September, 2006






